OverviewThis is a summary of the European public assessment report (EPAR) for Voriconazole Hikma. It explains how the Agency assessed the medicine to...
OverviewThis is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP)...
OverviewEntresto is a heart medicine used in adults with chronic (long-term) heart failure who have symptoms of the disease and reduced ejection fraction...
OverviewThis is a summary of the European public assessment report (EPAR) for Twynsta. It explains how the Committee for Medicinal Products for Human...
OverviewPravafenix is used in adults at high risk of heart disease whose low-density-lipoprotein (LDL) cholesterol is already being controlled with pravastatin alone or...
EMA has recommended the approval of the vaccines Bluevac-3 and Syvazul BTV 3 to protect sheep against bluetongue disease. Bluevac-3 is also approved...
OverviewThis is a summary of the European public assessment report (EPAR) for PritorPlus. It explains how the Committee for Medicinal Products for Human...
OverviewThis is a summary of the European public assessment report (EPAR) for MicardisPlus. It explains how the Committee for Medicinal Products for Human...
OverviewThis is a summary of the European public assessment report (EPAR) for Kinzalkomb. It explains how the Committee for Medicinal Products for Human...
OverviewVaxneuvance is a vaccine used to protect against three types of infections caused by the bacterium Streptococcus pneumoniae (S. pneumoniae):acute otitis media (ear...